Choksi Laborator Share Price ₹201 | P/E 69.8

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Choksi Laborator

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	9.78	8.88	7.95	8.79	11.12	10.74	9.26	10.38	11.40	11.24	11.12	10.82	12.82
Expenses +	6.30	6.45	5.84	6.55	7.63	7.91	6.90	7.84	7.90	8.34	8.19	8.16	9.18
Operating Profit	3.48	2.43	2.11	2.24	3.49	2.83	2.36	2.54	3.50	2.90	2.93	2.66	3.64
OPM %	35.58%	27.36%	26.54%	25.48%	31.38%	26.35%	25.49%	24.47%	30.70%	25.80%	26.35%	24.58%	28.39%
Other Income +	2.26	0.00	0.05	0.00	0.06	0.01	0.01	0.01	0.04	0.00	0.01	0.89	0.06
Interest	0.94	0.82	0.74	0.67	0.77	0.72	0.66	0.69	0.58	0.60	0.69	0.81	0.71
Depreciation	1.42	1.39	1.41	1.43	1.49	1.50	1.61	1.68	1.70	1.68	1.69	1.83	1.89
Profit before tax	3.38	0.22	0.01	0.14	1.29	0.62	0.10	0.18	1.26	0.62	0.56	0.91	1.10
Tax %	11.54%	-59.09%	0.00%	57.14%	46.51%	30.65%	20.00%	44.44%	26.98%	38.71%	57.14%	64.84%	6.36%
Net Profit +	2.99	0.36	0.01	0.06	0.68	0.42	0.08	0.11	0.92	0.39	0.24	0.31	1.03
EPS in Rs	4.29	0.52	0.01	0.09	0.98	0.60	0.11	0.16	1.32	0.56	0.34	0.45	1.48

Financials of Choksi Laborator

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	24.45	25.10	28.63	30.40	33.74	28.16	25.69	30.04	34.44	36.70	41.78	46.01
Expenses +	19.30	19.95	23.85	24.06	26.48	24.62	21.57	21.14	24.17	26.42	30.48	33.88
Operating Profit	5.15	5.15	4.78	6.34	7.26	3.54	4.12	8.90	10.27	10.28	11.30	12.13
OPM %	21.06%	20.52%	16.70%	20.86%	21.52%	12.57%	16.04%	29.63%	29.82%	28.01%	27.05%	26.36%
Other Income +	0.63	-0.05	0.86	0.35	0.25	-2.80	0.49	0.12	2.47	0.16	0.07	0.97
Interest	1.57	1.23	1.47	1.59	1.54	1.89	2.82	3.23	3.52	3.06	2.72	2.82
Depreciation	2.83	2.73	2.86	3.16	3.68	4.56	4.60	5.43	5.50	5.71	6.50	7.09
Profit before tax	1.38	1.14	1.31	1.94	2.29	-5.71	-2.81	0.36	3.72	1.67	2.15	3.19
Tax %	36.23%	36.84%	32.06%	29.90%	30.13%	-32.05%	-7.12%	44.44%	13.71%	32.93%	29.30%	38.56%
Net Profit +	0.88	0.72	0.89	1.35	1.60	-3.88	-2.61	0.21	3.21	1.11	1.52	1.96
EPS in Rs	1.26	1.03	1.28	1.94	2.30	-5.57	-3.75	0.30	4.61	1.59	2.18	2.81
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials of Choksi Laborator

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6.97	6.97	6.97	6.97	6.97	6.97	6.97	6.97	6.97	6.97	6.97	6.97
Reserves	12.35	13.07	14.16	15.43	17.04	13.26	10.78	10.94	14.14	15.25	16.64	18.61
Borrowings +	11.65	13.68	11.20	12.43	17.05	31.64	39.15	37.29	32.41	30.87	29.15	30.82
Other Liabilities +	6.70	8.81	8.32	9.85	14.28	13.14	9.48	9.22	6.84	8.86	12.57	15.52
Total Liabilities	37.67	42.53	40.65	44.68	55.34	65.01	66.38	64.42	60.36	61.95	65.33	71.92
Fixed Assets +	19.28	17.64	22.23	28.62	34.81	33.08	50.32	46.56	44.83	43.43	47.61	51.55
CWIP	2.73	8.99	4.28	0.00	3.23	13.06	0.50	1.67	0.31	2.99	0.00	0.40
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets +	15.66	15.90	14.14	16.06	17.30	18.87	15.56	16.19	15.22	15.53	17.72	19.97
Total Assets	37.67	42.53	40.65	44.68	55.34	65.01	66.38	64.42	60.36	61.95	65.33	71.92

Financials of Choksi Laborator

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	2.30	0.01	6.57	6.25	6.91	2.87	5.90	7.88	8.25	11.55	11.78	7.86
Cash from Investing Activity +	-0.73	-0.01	-1.88	-4.92	-9.76	-13.76	-7.65	-2.71	-0.71	-6.65	-7.61	-7.07
Cash from Financing Activity +	-1.37	0.00	-4.89	-0.94	2.13	11.09	1.63	-5.07	-7.61	-4.58	-4.22	-1.20
Net Cash Flow	0.21	0.00	-0.20	0.39	-0.72	0.20	-0.12	0.10	-0.07	0.32	-0.04	-0.41
Free Cash Flow	1.40	0.00	4.18	1.30	-3.09	-11.18	-2.18	5.05	7.34	4.54	4.09	0.62
CFO/OP	53%	0%	124%	124%	137%	111%	68%	75%	73%	117%	122%	69%

Financials of Choksi Laborator

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	126.15	124.77	112.19	118.62	95.09	90.60	115.94	125.03	112.87	103.33	98.46	116.85
Inventory Days	0.00	0.00	28.27	30.50	37.89	20.28	15.62	46.09	34.68	51.33	65.94	25.47
Days Payable			591.13	594.31	660.70	723.24	685.97	741.06	297.29	560.33	639.34	594.19
Cash Conversion Cycle	126.15	124.77	-450.67	-445.18	-527.72	-612.36	-554.41	-569.95	-149.73	-405.67	-474.95	-451.87
Working Capital Days	29.26	3.34	-23.71	-18.37	28.02	21.13	-49.73	-23.33	11.66	-49.13	-71.29	-35.14
ROCE %	7.94%	7.51%	7.33%	10.51%	10.09%	-1.48%	0.00%	6.40%	9.16%	8.87%	9.20%	9.64%

Manipal Health Enterprises Ltd (Q1 FY27)
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
Fortis Healthcare Ltd (Q1 FY27)
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
Metropolis Healthcare Ltd (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
Apollo Hospitals Enterprise Ltd (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

Choksi Laborator Share Price & Earnings Call Analysis